Results 1 to 2 of 2

Thread: New Israeli Anti-Diabetes Drug Could be a Game-Changer for Millions of Patients

  1. #1

    New Israeli Anti-Diabetes Drug Could be a Game-Changer for Millions of Patients


    New Israeli Anti-Diabetes Drug Could be a Game-Changer for Millions of Patients
    01-17-2020
    Emily Jones
    New Israeli Anti-Diabetes Drug Could be a Game-Changer for Millions of Patients | CBN News

    JERUSALEM, Israel
    – An Israeli company based in Jerusalem is developing a drug that could change the lives of countless people suffering from Type 2 diabetes.

    Concenter BioPharma created a new non-steroidal anti-inflammatory drug called Zygosid-50 that targets the disease at its source by restoring the body's sensitivity to insulin.

    Insulin is the hormone that keeps your blood sugar from getting too high after you eat. Type 2 diabetes occurs when the body is no longer sensitive to insulin or the pancreas does not make enough.

    Concenter Biopharma cofounder and CSO Prof. Mottie (Mordechai) Chevion developed the drug at Hebrew University-Hadassah Medical Center in Jerusalem.

    "Zygosids work by robustly reducing insulin resistance and normalizing all diabetes-associated parameters to the normal range," the professor told ISRAEL21c. "On the molecular level, Zygosid-50 is a potent anti-inflammatory drug that forces an intra-cellular exchange – removal of 'bad' free iron with zinc, depositing the zinc ion within the cells."

    When researchers tested Zygosid-50 on animals, it was able to restore insulin sensitivity by more than 90%, lowered glucose, and suppressed high inflammation levels within the body.

    Chevion explained that the drug had no bad side effects on animals. Now, the company is working to get the new drug approved by the United States Food and Drug Administration.

    The FDA has already approved clinical trials after the company completes a series of pre-clinical toxicology studies on the drug.

    "We are working on accommodating those requests and making the final formulation of the drug as a pill. We plan to perform clinical studies here in Israel. Then we will submit another IND (Investigational New Drug) application to go to phase 2b, by the end of 2020. ...









    This I say therefore, and testify in the Lord, that ye henceforth walk not as other Gentiles walk, in the vanity (futility) of their mind, having the understanding darkened...
    (Ephesians 4:17-18)

    Blessed is the man that walketh not in the counsel of the ungodly...
    (Psalm 1)

  2. #2
    Good that they did that, but if they'd start eating right they'd get their insulin sensitivity back. Type 2 diabetes is a dietary disease. You eat yourself into it. You can eat yourself out of it. And I don't mean just losing weight. Have to cut out the carbs that caused that insulin sensitivity in the first place.

    But why do it 'right' when you can just throw a drug at it?

Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
You can avoid major, expensive repair costs with an extended service plan for your Chevrolet. We cover all Chevy models including the Chevrolet Malibu.